Helicobacter Pylori Eradication With a New Sequential Treatment

• Status: Completed
• Trial end date: 2001-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Eradication rates of Helicobacter pylori (H. pylori) with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. The study aimed to assess the eradication rate of a new sequential treatment regimen compared with conventional triple therapy for the eradication of H. pylori infection.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna; St. Orsola Hospital

Criteria

Inclusion Criteria:

• Presence of active H. pylori infection

• Age >18 years

Exclusion Criteria:

• Allergy to drug administered

• Liver or kidney failure

• Pregnancy

• Previous treatment for H. pylori infection